Retraction: Zoledronic Acid Restores Doxorubicin Chemosensitivity and Immunogenic Cell Death in Multidrug-Resistant Human Cancer Cells.
出版信息
PLoS One. 2020 Dec 15;15(12):e0244194. doi: 10.1371/journal.pone.0244194. eCollection 2020.
Abstract
摘要
相似文献
1
Retraction: Zoledronic Acid Restores Doxorubicin Chemosensitivity and Immunogenic Cell Death in Multidrug-Resistant Human Cancer Cells.
PLoS One. 2020 Dec 15;15(12):e0244194. doi: 10.1371/journal.pone.0244194. eCollection 2020.
2
In vitro evaluation of zoledronic acid resistance developed in MCF-7 cells.
Anticancer Res. 2007 Nov-Dec;27(6B):4031-7.
3
Increased anti-tumour effects of doxorubicin and zoledronic acid in prostate cancer cells in vitro: supporting the benefits of combination therapy.
Cancer Chemother Pharmacol. 2010 Apr;65(5):969-78. doi: 10.1007/s00280-009-1106-6.
4
Zoledronic acid-encapsulating self-assembling nanoparticles and doxorubicin: a combinatorial approach to overcome simultaneously chemoresistance and immunoresistance in breast tumors.
Oncotarget. 2016 Apr 12;7(15):20753-72. doi: 10.18632/oncotarget.8012.
5
Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
Biochim Biophys Acta. 2014 Jan;1840(1):615-25. doi: 10.1016/j.bbagen.2013.10.023. Epub 2013 Oct 24.
6
Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone.
Mol Cancer Ther. 2009 Oct;8(10):2821-32. doi: 10.1158/1535-7163.MCT-09-0462. Epub 2009 Sep 29.
7
Differential effect of doxorubicin and zoledronic acid on intraosseous versus extraosseous breast tumor growth in vivo.
Clin Cancer Res. 2008 Jul 15;14(14):4658-66. doi: 10.1158/1078-0432.CCR-07-1545.
8
Bone microenvironment-related growth factors modulate differentially the anticancer actions of zoledronic acid and doxorubicin on PC-3 prostate cancer cells.
Prostate. 2004 May 1;59(2):120-31. doi: 10.1002/pros.10363.
9
Hexane fraction of adlay (Coix lachryma-jobi L.) testa ethanolic extract inhibits human uterine sarcoma cancer cells growth and chemosensitizes human uterine sarcoma cells to doxorubicin.
Phytomedicine. 2018 Aug 1;47:69-80. doi: 10.1016/j.phymed.2018.03.056. Epub 2018 Mar 21.
10
Multidrug resistance-1 and p-glycoprotein in human chondrosarcoma cell lines: expression correlates with decreased intracellular doxorubicin and in vitro chemoresistance.
J Orthop Res. 1999 Nov;17(6):935-40. doi: 10.1002/jor.1100170619.
本文引用的文献
1
Zoledronic acid restores doxorubicin chemosensitivity and immunogenic cell death in multidrug-resistant human cancer cells.
PLoS One. 2013 Apr 12;8(4):e60975. doi: 10.1371/journal.pone.0060975. Print 2013.
Zotero 插件